J&J multiple myeloma drug offers hope after others stop working -study

May 30 (Reuters) - An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday.